Hironori Harada
Tokyo University of Pharmacy and Life Sciences(JP)Tokyo Metropolitan Komagome Hospital(JP)
Publications by Year
Research Areas
Acute Myeloid Leukemia Research, Myeloproliferative Neoplasms: Diagnosis and Treatment, Chronic Myeloid Leukemia Treatments, Histone Deacetylase Inhibitors Research, Acute Lymphoblastic Leukemia research
Most-Cited Works
- → Expression of a Knocked-In AML1-ETO Leukemia Gene Inhibits the Establishment of Normal Definitive Hematopoiesis and Directly Generates Dysplastic Hematopoietic Progenitors(1998)351 cited
- → ETO, a Target of t(8;21) in Acute Leukemia, Makes Distinct Contacts with Multiple Histone Deacetylases and Binds mSin3A through Its Oligomerization Domain(2001)339 cited
- → High incidence of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome and low blast percentage myeloid leukemia with myelodysplasia(2003)276 cited
- → Hypoxia/pseudohypoxia‐mediated activation of hypoxia‐inducible factor‐1α in cancer(2019)196 cited
- → Myelodysplastic syndromes are induced by histone methylation–altering ASXL1 mutations(2013)172 cited
- → Ezh2 loss promotes development of myelodysplastic syndrome but attenuates its predisposition to leukaemic transformation(2014)